SET Domain Containing 2 (SETD2) Peptide
-
- Target See all SETD2 products
- SETD2 (SET Domain Containing 2 (SETD2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SETD2 antibody (Catalog #: ARP47617_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SETD2 (SET Domain Containing 2 (SETD2))
- Synonyms
- Kif9 Peptide, HBP231 Peptide, HIF-1 Peptide, HIP-1 Peptide, HYPB Peptide, KMT3A Peptide, SET2 Peptide, p231HBP Peptide, SET domain containing 2 Peptide, Setd2 Peptide, SETD2 Peptide
- Background
-
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. SETD2 is a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs.
Alias Symbols: FLJ16420, FLJ22472, FLJ23184, FLJ45883, HIF-1, HSPC069, HYPB, KIAA1732, KMT3A, SET2, HIP-1, HBP231, p231HBP
Protein Interaction Partner: HTT,SETD2,ATXN1,CIC,HTT,SETD2,HTT
Protein Size: 891 - Molecular Weight
- 97 kDa
- Gene ID
- 29072
- NCBI Accession
- NM_014159
- UniProt
- Q9BYW2
-